Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Italy

Recordati Increases Presence In Turkey

October 2008 | Company News Alert

Leading Italian drugmaker Recordati increased its profile in Turkey following the acquisition of local manufacturer Yeni Ilaç. The deal - valued at EUR48mn (US$63mn) and funded from existing liquidity - is the Italian firm's second major expansion in Central and Eastern Europe (CEE) in 2008 and represents the company's strategy of increasing its exposure in more dynamic

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
IMF Warns Over Health Spending

Companies / Turkey The International Monetary Fund (IMF) has warned Turkey over its health spending, which it claims has risen dramatically from 3.7% of GDP in 1999 to 5% in 2005. This is now allegedly higher than in...
November 2006
Roche Compensates Government

Companies / Turkey Swiss drugmaker Roche has paid compensation of EUR1.4mn (US$1.76mn) to the Turkish Health Ministry after allegedly causing the government to incur substantial losses by overcharging for drugs. However,...
October 2006
Sanovel Ilac Opens New Plant

Companies / Turkey Turkish drugmaker Sanovel Ilac will open its new TRY192mn (US$144.85mn) production facility shortly. Construction on the 120,000 m2 plant began in 2001and when fully operational it will have an annual...
April 2006
Eczacibiasi Opens New Antibiotics Factory

Companies / Turkey Turkish drugmaker Eczacibasi Pharmaceuticals has recently opened a new US$4mn antibiotics facility, which will specialise in the production of cephalosporin. Eczacibasi Pharmaceuticals is planning to...
March 2006
Sandoz Re-enters Turkish Market

Companies / Turkey Generics maker Sandoz, a division of Swiss drugmaker Novartis, has re-entered the Turkish market after an absence of more than a decade. When Novartis acquired German generics firm Hexal, the Ilsan Hexal...
March 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS